Impact of a Novel Wearable Sensor on Heart Failure Rehospitalization
In patients with a recent HF hospitalization, a strategy of using HFMS data for HF management is associated with a 38% relative risk reduction in 90-day HF rehospitalization. (Benefits of Microcor in Ambulatory Decompensated Heart Failure [BMAD-TX]; NCT04096040; Benefits of Microcor in Ambulatory Decompensated Heart Failure [BMAD-HF]; NCT03476187).
Authors
- John Boehmer (ORCID: https://orcid.org/0000-0002-8024-1589)
- Patrick J. McCann (ORCID: https://orcid.org/0000-0002-9854-2005)
- Wael Abo-Auda
- Ashley E. Burch (ORCID: https://orcid.org/0000-0003-3871-6349)
- Sebastian Cremer (ORCID: https://orcid.org/0000-0002-6409-9279)
- Diana Bonderman
- Donny R Stokes
- Azam Hadi
Institutions
- Goethe University Frankfurt (DE)
- Prisma Health (US)
- Allegheny Health Network (US)
- East Carolina University (US)
- Jackson Memorial Hospital (US)
- University Hospital Frankfurt (DE)
- Kidney Associates (US)
- Medical University of Vienna (AT)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- JACC Heart Failure
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1016/j.jchf.2024.07.022
- Citations
- 39
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 15.68
Funders
- ZOLL Medical Corporation